NCT06364891

Brief Summary

VMMC has been identified as a crucial intervention by UNAIDS to achieve the 2030 global target of a 90% reduction in new HIV infections compared with 2010 levels. CIDRZ, a key partner to the Ministry of Health, has worked with DesireLine to develop a mobile application that supports mobilisers to segment potential clients and provide them with targeted messaging based on their segmentation type. The hypothesis of our proposed study is that targeted interventions addressing the barriers for each of the seven segments, assisted by the Digital Mobilization Tool, will better meet the needs of potential clients and therefore improve uptake of VMMC services, specifically among the three most-resistant segments. The objective of this study is to evaluate the effect of a segment-targeted mobilization intervention supported by the VMMC NEXUS Digital Mobilization Tool on the uptake of VMMC services at 30 intervention sites, compared with 30 control sites. The research questions are:

  • Assess the incremental cost of the intervention, including by MC
  • Assess and document process learnings from the intervention
  • Develop a workplan to enable national and regional scale-up of the mobilization model and NEXUS Digital Mobilization Tool if demonstrated as effective

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150,383

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 25, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 15, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

1.6 years

First QC Date

March 25, 2024

Last Update Submit

May 8, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Total number of VMMC's conducted in intervention vs control

    The study will compare the difference in total number of VMMC's conducted in the intervention versus the control arm

    at 12 months

  • Total number of VMMC's by segment

    The total number of VMMC's conducted in both the intervention and control arm will be compared by segment (ie the specific group type the men have been assigned to).

    at 12 months

  • Total number of VMMC's by age

    The total number of VMMC's conducted in both the intervention and control arm will be compared and stratified by age group.

    at 12 months

Secondary Outcomes (3)

  • Costing

    12 months

  • Process evaluation

    12 months

  • Develop a workplan and handbook to allow for the intervention to be scaled up elsewhere.

    3 months post study completion

Study Arms (2)

Intervention

OTHER

Mobilisers in the intervention sites will be trained to use a digital mobile application to assist with segmenting clients and providing them with targeted messaging.

Other: VMMC NEXUS Digital application

Control

OTHER

Mobilisers in the control arm have been sensitised to the segmentation process but only have access to paper based resources.

Other: VMMC NEXUS Digital application

Interventions

A handheld digital application which supports segmentation of potential VMMC Clients

ControlIntervention

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • living in the catchment area 18 or older

You may not qualify if:

  • nil

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ministry of Health facilities

Lusaka, Lusaka Province, 10101, Zambia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Cluster randomised control study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

March 25, 2024

First Posted

April 15, 2024

Study Start

October 1, 2023

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

May 13, 2025

Record last verified: 2025-05

Locations